Results 21 to 30 of about 5,476 (161)

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Comparison of efficacy and safety between rabbit anti-thymocyte globulin and anti-T lymphocyte globulin in kidney only transplantation: A retrospective observational study

open access: yesIndian Journal of Transplantation, 2022
Introduction: The two formulations of antihuman thymocyte immunoglobulin that are used as T-cell depleting induction agents in renal transplantation are anti-thymocyte globulins (ATG) thymoglobulin and (antiT-lymphocyte globulin [ATLG]-Grafalon-formerly ...
S Sakthi Selva Kumar   +5 more
doaj   +1 more source

ECMO RESCUE IN A PATIENT WITH THYMOGLOBULIN-INDUCED ARDS AFTER LIVER TRANSPLANTATION [PDF]

open access: yes, 2023
INTRODUCTION: Postoperative care after liver transplantation can be associated with significant cardiopulmonary complications. Thymoglobulin is used for prevention and treatment of acute rejection in organ transplantations.
Villalba, Paul S   +4 more
core   +1 more source

Complications of rabbit anti-thymocyte globulin induction immunosuppression in HIV-infected kidney transplant recipients

open access: yesFrontiers in Nephrology, 2022
BackgroundKidney transplantation in HIV-infected individuals with end-stage kidney disease is associated with improved survival compared to dialysis. Rabbit anti-thymocyte globulin (rATG) induction in HIV-infected kidney transplant recipients has been ...
Ayman Al Jurdi   +14 more
doaj   +1 more source

Desensitization therapy in kidney transplantation cases with positive baseline complement-dependent cytotoxicity crossmatch and high donor-specific antibodies: A retrospective study

open access: yesIndian Journal of Transplantation, 2021
Objective: The objective of the study is to assess the graft and patient outcome after desensitization in human leukocyte antigen incompatible kidney transplantation (KT) with positive baseline complement-dependent cytotoxic (CDC) crossmatch and high ...
Vijay Kumar Sinha   +6 more
doaj   +1 more source

Thymoglobulin vs. ATG-Fresenius as Induction Therapy in Kidney Transplantation: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

open access: yesFrontiers in Immunology, 2020
Background: Thymoglobulin (THG) and antithymocyte globulin-Fresenius (ATG-F) have not been compared directly as induction therapies in kidney transplantation.Materials and Methods: We performed a Bayesian network meta-analysis to compare THG with ATG-F ...
Turun Song   +7 more
doaj   +1 more source

Association of Polymorphisms in T-Cell Activation Costimulatory/Inhibitory Signal Genes With Allograft Kidney Rejection Risk

open access: yesFrontiers in Immunology, 2021
The genes CD28, CD86 and CTLA-4 conform the costimulatory (CD28-CD86) or inhibitory (CTLA-4-CD86) signal in T-cell activation. T-cell immune response has a critical role in allograft rejection, and single nucleotide polymorphisms (SNPs) located in these ...
Jose Luis Santiago   +8 more
doaj   +1 more source

A Retrospective Post-Marketing Surveillance Study on TGlobulin25®, the First Rabbit Anti-Thymocyte Globulin (r-ATG) Biosimilar Worldwide, as Induction Therapy in Adult Kidney Transplant Recipients [PDF]

open access: yesIranian Journal of Medical Sciences
Background: Post-marketing surveillance studies are essential to establish a realistic assessment of TGlobulin25®, the first rabbit anti-thymocyte globulin (rATG) biosimilar approved in Iran, for the prevention of acute kidney transplant rejection.
Mojtaba Shafiekhani   +8 more
doaj   +1 more source

Elevated Matrix Metalloproteinase Type 9 (MMP-9) Transcripts After Thymoglobulin Induction in Incident Kidney Transplant Recipients. [PDF]

open access: yesInt J Mol Sci
Matrix metalloproteinase type 9 (MMP-9), which cleaves collagen type IV in basal membranes, has been associated with the progression of chronic kidney disease.
Petersen TBB, Nagarajah S, Tepel M.
europepmc   +2 more sources

Comparison of Long-Term Effect of Thymoglobulin Treatment in Patients With a High Risk of Delayed Graft Function [PDF]

open access: yes, 2012
Background. T-lymphocyte depletion is a strategy to reverse the impact of ischemia-reperfusion injury (IRI) in progression to chronic allograft dysfunction, especially among patients at high risk for delayed graft function (DGF).Methods. the present work
Durão, Marcelino de Souza [UNIFESP]   +7 more
core   +3 more sources

Home - About - Disclaimer - Privacy